JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB83352

Recombinant HIV tat (mutated C22) protein

Be the first to review this product! Submit a review

|

(2 Publications)

Recombinant HIV tat (mutated C22) protein is a HIV-1 M:B_HXB2R Full Length protein, expressed in Escherichia coli, with >90%, suitable for SDS-PAGE, WB, BL, FuncS.

View Alternative Names

Protein Tat, Transactivating regulatory protein, tat, Tat, p14, Tat protein, Transactivating regulatory protein

Key facts

Purity

>90% SDS-PAGE

Expression system

Escherichia coli

Tags

Tag free

Applications

SDS-PAGE, FuncS, WB, BL

applications

Biologically active

No

Accession

P04608

Animal free

No

Carrier free

No

Species

HIV-1 M:B_HXB2R

Reconstitution

Reconstitute in water

Storage buffer

pH: 7.5 Constituents: 6.96% Sodium chloride, 2.5% Glycerol (glycerin, glycerine), 0.91% Mannitol, 0.328% Sodium phosphate, 0.284% Disodium hydrogenorthophosphate, 0.24% Sodium dihydrogen phosphate, 0.0154% (R*,R*)-1,4-Dimercaptobutan-2,3-diol

storage-buffer

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "BL": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "FuncS": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p>up-take and rescue assays.</p>" } } }

Product details

Reacts with anti-Tat antibodies from human, monkey, rabbit and mouse serum.

Sequence info

[{"sequence":"","proteinLength":"Full Length","predictedMolecularWeight":null,"actualMolecularWeight":null,"aminoAcidEnd":0,"aminoAcidStart":0,"nature":"Recombinant","expressionSystem":null,"accessionNumber":"P04608","tags":[]}]

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-80°C
Appropriate long-term storage conditions
-80°C
False

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The HIV tat protein also known as Trans-Activator of Transcription plays an important role in the replication of the Human Immunodeficiency Virus (HIV). It possesses a molecular mass of approximately 14 to 15 kDa and it is expressed in cells infected by HIV. The tat protein contains a domain that allows it to transactivate HIV-1 promoter located in the long terminal repeat (LTR) region of the viral genome. It binds to the TAR RNA element and recruits cellular transcription factors that are essential for effective viral replication.
Biological function summary

The HIV tat protein enhances the transcription of the HIV genome. It acts not only as a transcriptional activator but also modifies cellular environments to favor viral propagation. Tat is part of a transcriptional complex that includes RNA polymerase II Cyclin T1 and CDK9. This complex hyperphosphorylates the carboxy-terminal domain of RNA polymerase II which increases transcriptional elongation allowing complete synthesis of viral RNA.

Pathways

Interactions facilitated by the HIV tat protein significantly impact the host cell. It involves pathways such as the NF-κB and MAPK signaling cascades. These pathways are important for inflammation and cell survival processes. NF-κB a protein complex is often activated by tat through interaction with IκB kinase pushing the infected cell into a state favorable for viral production. Similarly tat-mediated activation of the MAPK pathway can enhance viral replication influencing proteins like ERK and JNK within the pathway.

The HIV tat protein is directly linked to the progression of AIDS and associated neurological disorders. By potentiating HIV replication it exacerbates immune suppression seen in AIDS. Tat also contributes to the development of HIV-associated neurocognitive disorders (HAND) by disrupting neuronal function and survival. Infected cells release tat which can then affect neurons and glial cells in the central nervous system. Through these mechanisms tat is associated with other proteins like Nef which also play roles in disease manifestation in HIV-infected individuals.

Specifications

Form

Lyophilized

General info

Function

Transcriptional activator that increases RNA Pol II processivity, thereby increasing the level of full-length viral transcripts. Recognizes a hairpin structure at the 5'-LTR of the nascent viral mRNAs referred to as the transactivation responsive RNA element (TAR) and recruits the cyclin T1-CDK9 complex (P-TEFb complex) that will in turn hyperphosphorylate the RNA polymerase II to allow efficient elongation. The CDK9 component of P-TEFb and other Tat-activated kinases hyperphosphorylate the C-terminus of RNA Pol II that becomes stabilized and much more processive. Other factors such as HTATSF1/Tat-SF1, SUPT5H/SPT5, and HTATIP2 are also important for Tat's function. Besides its effect on RNA Pol II processivity, Tat induces chromatin remodeling of proviral genes by recruiting the histone acetyltransferases (HATs) CREBBP, EP300 and PCAF to the chromatin. This also contributes to the increase in proviral transcription rate, especially when the provirus integrates in transcriptionally silent region of the host genome. To ensure maximal activation of the LTR, Tat mediates nuclear translocation of NF-kappa-B by interacting with host RELA. Through its interaction with host TBP, Tat may also modulate transcription initiation. Tat can reactivate a latently infected cell by penetrating in it and transactivating its LTR promoter. In the cytoplasm, Tat is thought to act as a translational activator of HIV-1 mRNAs.. Extracellular circulating Tat can be endocytosed by surrounding uninfected cells via the binding to several surface receptors such as CD26, CXCR4, heparan sulfate proteoglycans (HSPG) or LDLR. Neurons are rarely infected, but they internalize Tat via their LDLR. Through its interaction with nuclear HATs, Tat is potentially able to control the acetylation-dependent cellular gene expression. Modulates the expression of many cellular genes involved in cell survival, proliferation or in coding for cytokines or cytokine receptors. Tat plays a role in T-cell and neurons apoptosis. Tat induced neurotoxicity and apoptosis probably contribute to neuroAIDS. Circulating Tat also acts as a chemokine-like and/or growth factor-like molecule that binds to specific receptors on the surface of the cells, affecting many cellular pathways. In the vascular system, Tat binds to ITGAV/ITGB3 and ITGA5/ITGB1 integrins dimers at the surface of endothelial cells and competes with bFGF for heparin-binding sites, leading to an excess of soluble bFGF.

Sequence similarities

Belongs to the lentiviruses Tat family.

Post-translational modifications

Asymmetrical arginine methylation by host PRMT6 seems to diminish the transactivation capacity of Tat and affects the interaction with host CCNT1.. Acetylation by EP300, CREBBP, GCN5L2/GCN5 and PCAF regulates the transactivation activity of Tat. EP300-mediated acetylation of Lys-50 promotes dissociation of Tat from the TAR RNA through the competitive binding to PCAF's bromodomain. In addition, the non-acetylated Tat's N-terminus can also interact with PCAF. PCAF-mediated acetylation of Lys-28 enhances Tat's binding to CCNT1. Lys-50 is deacetylated by SIRT1.. Polyubiquitination by host MDM2 does not target Tat to degradation, but activates its transactivation function and fosters interaction with CCNT1 and TAR RNA.. Phosphorylated by EIF2AK2 on serine and threonine residues adjacent to the basic region important for TAR RNA binding and function. Phosphorylation of Tat by EIF2AK2 is dependent on the prior activation of EIF2AK2 by dsRNA.

Product protocols

Target data

Transcriptional activator that increases RNA Pol II processivity, thereby increasing the level of full-length viral transcripts. Recognizes a hairpin structure at the 5'-LTR of the nascent viral mRNAs referred to as the transactivation responsive RNA element (TAR) and recruits the cyclin T1-CDK9 complex (P-TEFb complex) that will in turn hyperphosphorylate the RNA polymerase II to allow efficient elongation. The CDK9 component of P-TEFb and other Tat-activated kinases hyperphosphorylate the C-terminus of RNA Pol II that becomes stabilized and much more processive. Other factors such as HTATSF1/Tat-SF1, SUPT5H/SPT5, and HTATIP2 are also important for Tat's function. Besides its effect on RNA Pol II processivity, Tat induces chromatin remodeling of proviral genes by recruiting the histone acetyltransferases (HATs) CREBBP, EP300 and PCAF to the chromatin. This also contributes to the increase in proviral transcription rate, especially when the provirus integrates in transcriptionally silent region of the host genome. To ensure maximal activation of the LTR, Tat mediates nuclear translocation of NF-kappa-B by interacting with host RELA. Through its interaction with host TBP, Tat may also modulate transcription initiation. Tat can reactivate a latently infected cell by penetrating in it and transactivating its LTR promoter. In the cytoplasm, Tat is thought to act as a translational activator of HIV-1 mRNAs.. Extracellular circulating Tat can be endocytosed by surrounding uninfected cells via the binding to several surface receptors such as CD26, CXCR4, heparan sulfate proteoglycans (HSPG) or LDLR. Neurons are rarely infected, but they internalize Tat via their LDLR. Through its interaction with nuclear HATs, Tat is potentially able to control the acetylation-dependent cellular gene expression. Modulates the expression of many cellular genes involved in cell survival, proliferation or in coding for cytokines or cytokine receptors. Tat plays a role in T-cell and neurons apoptosis. Tat induced neurotoxicity and apoptosis probably contribute to neuroAIDS. Circulating Tat also acts as a chemokine-like and/or growth factor-like molecule that binds to specific receptors on the surface of the cells, affecting many cellular pathways. In the vascular system, Tat binds to ITGAV/ITGB3 and ITGA5/ITGB1 integrins dimers at the surface of endothelial cells and competes with bFGF for heparin-binding sites, leading to an excess of soluble bFGF.
See full target information tat deleted C22

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

Journal of extracellular vesicles 13:e12439 PubMed38647111

2024

Neuropathogenic role of astrocyte-derived extracellular vesicles in HIV-associated neurocognitive disorders.

Applications

Unspecified application

Species

Unspecified reactive species

Divya T Chemparathy,Sudipta Ray,Chase Ochs,Natasha Ferguson,Dinesh Y Gawande,Shashank M Dravid,Shannon Callen,Susmita Sil,Shilpa Buch

Redox biology 15:97-108 PubMed29220699

2017

HIV-1 Tat protein induces DNA damage in human peripheral blood B-lymphocytes via mitochondrial ROS production.

Applications

Unspecified application

Species

Unspecified reactive species

Rawan El-Amine,Diego Germini,Vlada V Zakharova,Tatyana Tsfasman,Eugene V Sheval,Ruy A N Louzada,Corinne Dupuy,Chrystèle Bilhou-Nabera,Aline Hamade,Fadia Najjar,Eric Oksenhendler,Marс Lipinski,Boris V Chernyak,Yegor S Vassetzky
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com